Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity
2007

Racial and Ethnic Differences in Colorectal Cancer Survival

Sample size: 41901 publication 10 minutes Evidence: high

Author Information

Author(s): Gomez Scarlett Lin, O'Malley Cynthia D, Stroup Antoinette, Shema Sarah J, Satariano William A

Primary Institution: Northern California Cancer Center

Hypothesis

How do sociodemographic factors, tumor characteristics, neighborhood socioeconomic status, treatment, and comorbidities impact colorectal cancer survival across different racial/ethnic groups?

Conclusion

Racial and ethnic disparities in colorectal cancer survival persist, with significant differences attributed to stage and socioeconomic status.

Supporting Evidence

  • Colorectal cancer-specific mortality rates were higher among Blacks and Hispanic males than Whites.
  • Adjustment for stage accounted for the higher rate among Hispanic males and most of the lower rate among Japanese.
  • Among Blacks, stage and SES accounted for about half of the higher rate relative to Whites.

Takeaway

This study found that different races and ethnicities have different chances of surviving colorectal cancer, and this is influenced by factors like their stage of cancer and where they live.

Methodology

The study used the SEER-Medicare database to analyze colorectal cancer survival among patients diagnosed from 1992 to 1996, focusing on various sociodemographic and clinical factors.

Potential Biases

Potential misclassification of race/ethnicity and incomplete treatment data may introduce bias.

Limitations

The study may be limited by the quality of SEER and Medicare data, particularly regarding treatment completeness and race/ethnic misclassification.

Participant Demographics

Participants included Medicare-eligible patients aged 65 and older diagnosed with colorectal cancer, with a diverse representation of racial/ethnic groups.

Statistical Information

P-Value

1.14 (1.09–1.20) for all-cause mortality and 1.21 (1.14–1.29) for colorectal cancer specific mortality

Confidence Interval

95% CI for mortality rates provided in the results

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-7-193

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication